---
title: "4D Molecular Therapeutics to present at Wells Fargo, Cantor, Morgan Stanley healthcare investor conferences"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296911106.md"
description: "4D Molecular Therapeutics management will present at three healthcare investor conferences in September 2026: the Wells Fargo Healthcare Conference on Sept. 9, the Cantor Global Healthcare Conference on Sept. 10, and the Morgan Stanley Global Healthcare Conference on Sept. 14."
datetime: "2026-08-25T12:04:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296911106.md)
  - [en](https://longbridge.com/en/news/296911106.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296911106.md)
generator: "portal-rs"
---

# 4D Molecular Therapeutics to present at Wells Fargo, Cantor, Morgan Stanley healthcare investor conferences

-   4D Molecular Therapeutics management will present at the Wells Fargo 2026 Healthcare Conference on Sept. 9, 2026. \* Participation continues at the 2026 Cantor Global Healthcare Conference on Sept. 10, 2026, including a fireside chat at 10:20 a.m. ET. \* Appearances conclude at the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 14, 2026, with a fireside chat at 5:35 p.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608250800PRIMZONEFULLFEED9815263) on August 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [FDMT.US](https://longbridge.com/en/quote/FDMT.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [Morgan Stanley lifts Teleperformance stake above 5% to 5.02% of share capital](https://longbridge.com/en/news/296903651.md)
- [Morgan Stanley Q2 2026: Record Revenue $21.35B (+27%), EPS Surge 62%, ROTCE 26.6%, $1.5T Infrastructure Initiative](https://longbridge.com/en/news/296805663.md)
- [Lumexa Imaging CEO, CFO to join Wells Fargo healthcare conference fireside chat](https://longbridge.com/en/news/296901710.md)
- [Is Morgan Stanley’s (MS) Steady Preferred Dividends Quietly Redefining Its Capital-Return Priorities?](https://longbridge.com/en/news/296658813.md)
- [4D Molecular Therapeutics CEO David Kirn disposes of common shares worth $1,068,651.63](https://longbridge.com/en/news/296648682.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**